Pipenzolate bromide

Chemical compound
  • A03AB14 (WHO)
Identifiers
  • 1-Ethyl-3-[2-hydroxy(diphenyl)acetoxy]-1-methylpiperidinium bromide
CAS Number
  • 125-51-9 checkY
PubChem CID
  • 657306
ChemSpider
  • 571430 ☒N
UNII
  • JPX41DUS2B
ChEMBL
  • ChEMBL1401367 ☒N
CompTox Dashboard (EPA)
  • DTXSID2023480 Edit this at Wikidata
ECHA InfoCard100.004.311 Edit this at WikidataChemical and physical dataFormulaC22H28BrNO3Molar mass434.374 g·mol−13D model (JSmol)
  • Interactive image
  • CC[N+]1(CCCC(C1)OC(=O)C(c2ccccc2)(c3ccccc3)O)C.[Br-]
InChI
  • InChI=1S/C22H28NO3.BrH/c1-3-23(2)16-10-15-20(17-23)26-21(24)22(25,18-11-6-4-7-12-18)19-13-8-5-9-14-19;/h4-9,11-14,20,25H,3,10,15-17H2,1-2H3;1H/q+1;/p-1 ☒N
  • Key:XEDCWWFPZMHXCM-UHFFFAOYSA-M ☒N
 ☒NcheckY (what is this?)  (verify)

Pipenzolate bromide is a pharmaceutical drug that has been studied as an antispasmodic agent and to treat peptic ulcer.[1]

Mechanism of action

Pipenzolate bromide acts as an antimuscarinic agent. It binds to muscarinic acetylcholine receptors as an antagonist therefore preventing acetylcholine from binding to the receptors.[1]

References

  1. ^ a b "Pipenzolate". Inxight Drugs. National Center for Advancing Translational Sciences.


  • v
  • t
  • e
Drugs for functional gastrointestinal disorders (A03)
Drugs for
functional
bowel
disorders
Antimuscarinics
Tertiary
amino group
Quaternary
ammonium
compounds
Phosphodiesterase
inhibitors
Acting on
serotonin receptors
Other
Belladonna
and derivatives
(antimuscarinics)Propulsives
  • v
  • t
  • e
mAChRsTooltip Muscarinic acetylcholine receptors
Agonists
Antagonists
Precursors
(and prodrugs)
See also
Receptor/signaling modulators
Nicotinic acetylcholine receptor modulators
Acetylcholine metabolism/transport modulators


Stub icon

This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e